Graves Austin R, Curran Patricia K, Smith Carolyn L, Mindell Joseph A
Membrane Transport Biophysics Unit, Porter Neuroscience Research Center, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 35 Convent Drive, Building 35, MSC 3701, Bethesda, Maryland 20892, USA.
Nature. 2008 Jun 5;453(7196):788-92. doi: 10.1038/nature06907. Epub 2008 Apr 30.
Lysosomes are the stomachs of the cell-terminal organelles on the endocytic pathway where internalized macromolecules are degraded. Containing a wide range of hydrolytic enzymes, lysosomes depend on maintaining acidic luminal pH values for efficient function. Although acidification is mediated by a V-type proton ATPase, a parallel anion pathway is essential to allow bulk proton transport. The molecular identity of this anion transporter remains unknown. Recent results of knockout experiments raise the possibility that ClC-7, a member of the CLC family of anion channels and transporters, is a contributor to this pathway in an osteoclast lysosome-like compartment, with loss of ClC-7 function causing osteopetrosis. Several mammalian members of the CLC family have been characterized in detail; some (including ClC-0, ClC-1 and ClC-2) function as Cl--conducting ion channels, whereas others act as Cl-/H+antiporters (ClC-4 and ClC-5). However, previous attempts at heterologous expression of ClC-7 have failed to yield evidence of functional protein, so it is unclear whether ClC-7 has an important function in lysosomal biology, and also whether this protein functions as a Cl- channel, a Cl-/H+ antiporter, or as something else entirely. Here we directly demonstrate an anion transport pathway in lysosomes that has the defining characteristics of a CLC Cl-/H+ antiporter and show that this transporter is the predominant route for Cl- through the lysosomal membrane. Furthermore, knockdown of ClC-7 expression by short interfering RNA can essentially ablate this lysosomal Cl-/H+ antiport activity and can strongly diminish the ability of lysosomes to acidify in vivo, demonstrating that ClC-7 is a Cl-/H+ antiporter, that it constitutes the major Cl- permeability of lysosomes, and that it is important in lysosomal acidification.
溶酶体是细胞的“胃”——内吞途径中的终末细胞器,内化的大分子在此被降解。溶酶体含有多种水解酶,其高效功能依赖于维持酸性的腔pH值。虽然酸化由V型质子ATP酶介导,但平行的阴离子途径对于大量质子运输至关重要。这种阴离子转运体的分子身份仍然未知。基因敲除实验的最新结果提出了一种可能性,即氯离子通道和转运体CLC家族的成员ClC-7是破骨细胞溶酶体样区室中该途径的一个促成因素,ClC-7功能丧失会导致骨硬化症。CLC家族的几个哺乳动物成员已被详细表征;一些(包括ClC-0、ClC-1和ClC-2)作为Cl-传导离子通道发挥作用,而其他成员则作为Cl-/H+反向转运体(ClC-4和ClC-5)。然而,先前对ClC-7进行异源表达的尝试未能获得功能性蛋白的证据,因此尚不清楚ClC-7在溶酶体生物学中是否具有重要功能,也不清楚该蛋白是作为Cl-通道、Cl-/H+反向转运体,还是完全作为其他物质发挥作用。在这里,我们直接证明了溶酶体中的一种阴离子转运途径具有CLC Cl-/H+反向转运体的典型特征,并表明该转运体是Cl-通过溶酶体膜的主要途径。此外,通过短干扰RNA敲低ClC-7的表达可基本消除这种溶酶体Cl-/H+反向转运活性,并能显著降低溶酶体在体内酸化的能力,这表明ClC-7是一种Cl-/H+反向转运体,它构成了溶酶体的主要Cl-通透性,并且在溶酶体酸化中起重要作用。